Seoul National University medical professors Mook In-hee and Lee Dong-yeong said on October 23 that their research team developed a blood test-based Alzheimer’s disease prediction technique and transferred the technique with a prediction accuracy of about 90% to Medifron DBT. 130 million won was paid in advance for the technology transfer and the running royalty is equivalent to 3% of net sales.